SCRS Welcomes Roche as a New Global Impact Partner
The Society for Clinical Research Sites (SCRS) announces that Roche has become a Global Impact Partner (GIP).
The Society for Clinical Research Sites (SCRS) announces that Roche has become a Global Impact Partner (GIP). Through this partnership, Roche will serve on the SCRS Global Impact Board and work closely with the organization’s Leadership Council working toward strategic initiatives.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025